AR030262A1 - Derivados de acido 15-hidroxieicosatetraenoico modificados de cadena omega , composiciones que lo comprenden y el uso de los mismos para la manufactura de un medicamento para su utilizacion en el tratamiento del ojo seco - Google Patents
Derivados de acido 15-hidroxieicosatetraenoico modificados de cadena omega , composiciones que lo comprenden y el uso de los mismos para la manufactura de un medicamento para su utilizacion en el tratamiento del ojo secoInfo
- Publication number
- AR030262A1 AR030262A1 ARP000105875A ARP000105875A AR030262A1 AR 030262 A1 AR030262 A1 AR 030262A1 AR P000105875 A ARP000105875 A AR P000105875A AR P000105875 A ARP000105875 A AR P000105875A AR 030262 A1 AR030262 A1 AR 030262A1
- Authority
- AR
- Argentina
- Prior art keywords
- free
- functionally modified
- group
- alkyl
- hydroxy group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/46—Unsaturated compounds containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Derivados de ácido 15-hidroxieicosatetraenoico modificados de cadena omega, que comprenden un compuesto de la formula 1 donde: R1 es CO2R, CONR2R3, CO2OR4, CH2NR5R6, CH2N3, CH2Hal, CH2NO2, CH2SR20, COSR21, o 2,3,4,5-tetrazol-1-il, donde; R es H o forma una sal aceptable para uso farmacéutico; o CO2R forma un éster aceptable para uso farmacéutico; NR2R3 y NR5R6 son iguales o diferentes y comprenden un grupo amino libre o funcionalmente modificado; OR4 comprende un grupo hidroxi libre o funcionalmente modificado; Hal es F, Cl, Br, o I; SR20 comprende un grupo tilo libre o funcionalmente modificado; R21 forma un grupo funcional de tioéster aceptable para uso farmacéutico; A, B, C y D son un alquilo de C1-5, alquenilo C2-5, ciclopropilo C1-5, alquinilo C3-5 o un grupo alenilo C3-5; E es formula 2 o 3 donde OR7 comprende un grupo hidroxi libre o funcionalmente modificado; X =(CH2)m o (CH2) mO, donde m = 1-6; e Y = un anillo de fenilo opcionalmente sustituido con alquilo, halo, trihalometilo, acilo o un grupo amino, tiloo hidroxi libre o funcionalmente modificado; o X-Y =(CH2) pY1; donde p = 0-6; y Y' es de Formula 4 o 5 donde: W = CH2, O, S(O) q, NR8, CH2CH2, CH = CH, CH2O, CH2S(O) q, CH = N, o CH2NR8; donde q = 0-2, y R8 = H, alquilo o acilo; Z = H, alquilo, acilo, halo, trihalometilo, o un grupo amino, tiol, o hidroxi libre o funcionalmente modificado; y ---- = union simple o doble; o X - Y = ciclohexilo, composiciones que los comprenden y el uso de los mismos para la manufactura de un medicamento para su utilizacion en el tratamiento del ojo seco.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16437599P | 1999-11-09 | 1999-11-09 | |
| US21158700P | 2000-06-15 | 2000-06-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR030262A1 true AR030262A1 (es) | 2003-08-20 |
Family
ID=26860505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000105875A AR030262A1 (es) | 1999-11-09 | 2000-11-08 | Derivados de acido 15-hidroxieicosatetraenoico modificados de cadena omega , composiciones que lo comprenden y el uso de los mismos para la manufactura de un medicamento para su utilizacion en el tratamiento del ojo seco |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6326499B1 (es) |
| EP (1) | EP1228031B1 (es) |
| JP (1) | JP2003513946A (es) |
| KR (1) | KR20020050237A (es) |
| CN (1) | CN1387504A (es) |
| AR (1) | AR030262A1 (es) |
| AT (1) | ATE257144T1 (es) |
| AU (1) | AU775290B2 (es) |
| BR (1) | BR0015402A (es) |
| CA (1) | CA2386632A1 (es) |
| DE (1) | DE60007548T2 (es) |
| DK (1) | DK1228031T3 (es) |
| ES (1) | ES2208440T3 (es) |
| HK (1) | HK1045984B (es) |
| MX (1) | MXPA02004699A (es) |
| PL (1) | PL356127A1 (es) |
| PT (1) | PT1228031E (es) |
| TR (1) | TR200201251T2 (es) |
| TW (1) | TWI241290B (es) |
| WO (1) | WO2001034546A2 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0119583D0 (en) * | 2001-08-10 | 2001-10-03 | Unilever Plc | Cosmetic composition and method of treating skin |
| WO2003030894A1 (en) * | 2001-10-11 | 2003-04-17 | Alcon, Inc. | Methods for treating dry eye |
| WO2003030892A1 (en) * | 2001-10-11 | 2003-04-17 | Alcon, Inc. | Methods for treating dry eye |
| US20030109509A1 (en) * | 2001-10-11 | 2003-06-12 | Alcon, Inc. | Methods for treating dry eye |
| AU2003221707A1 (en) * | 2002-06-14 | 2003-12-31 | Alcon, Inc. | Topical use of hydroxyeicosatetraenoic acid compounds to treat psoriasis |
| AU2003235454A1 (en) * | 2002-06-14 | 2003-12-31 | Alcon, Inc. | Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders |
| PL374700A1 (en) * | 2002-09-20 | 2005-10-31 | Alcon, Inc. | Use of cytokine synthesis inhibitors for the treatment of dry eye disorders |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3991759A (en) | 1975-10-28 | 1976-11-16 | Alza Corporation | Method and therapeutic system for treating aqueous deficient dry eye |
| US4131651A (en) | 1977-10-25 | 1978-12-26 | Barnes-Hind Pharmaceuticals, Inc. | Treatment of dry eye |
| US4409205A (en) | 1979-03-05 | 1983-10-11 | Cooper Laboratories, Inc. | Ophthalmic solution |
| US4370325A (en) | 1979-03-30 | 1983-01-25 | Dermik Laboratories | Pharmaceutical compositions and method of treatment |
| AU546872B2 (en) | 1982-06-16 | 1985-09-26 | Unilever Plc | Skin treatment compositions containing a fatty acid or ester |
| US4421748A (en) | 1982-07-13 | 1983-12-20 | Trager Seymour F | Artificial tear aid |
| GB8319073D0 (en) | 1983-07-14 | 1983-08-17 | Efamol Ltd | Fatty acid compositions |
| US4753945A (en) | 1986-02-19 | 1988-06-28 | Eye Research Institute Of Retina Foundation | Stimulation of tear secretion with phosphodiesterase inhibitors |
| US4868154A (en) | 1986-02-19 | 1989-09-19 | Eye Research Institute Of Retina Foundation | Stimulation of tear secretion with melanocyte stimulating hormones |
| US4883658A (en) | 1986-04-28 | 1989-11-28 | Holly Frank J | Ophthalmic solution for treatment of dry-eye syndrome |
| US4744980A (en) | 1986-04-28 | 1988-05-17 | Holly Frank J | Ophthalmic solution for treatment of dry eye syndrome |
| US4804539A (en) | 1986-07-28 | 1989-02-14 | Liposome Technology, Inc. | Ophthalmic liposomes |
| US4818537A (en) | 1986-10-21 | 1989-04-04 | Liposome Technology, Inc. | Liposome composition for treating dry eye |
| US4966773A (en) | 1986-11-25 | 1990-10-30 | Alcon Laboratories, Inc. | Topical ophthalmic compositions containing microfine retinoid particles |
| US5278151A (en) | 1987-04-02 | 1994-01-11 | Ocular Research Of Boston, Inc. | Dry eye treatment solution |
| US4914088A (en) | 1987-04-02 | 1990-04-03 | Thomas Glonek | Dry eye treatment solution and method |
| US4921644A (en) | 1988-02-29 | 1990-05-01 | Technology Unlimited, Inc. | Mucin directed lipsome |
| US4906467A (en) | 1988-03-24 | 1990-03-06 | New York Medical College | Novel, long-duration treatment for glaucoma |
| US4923700A (en) | 1988-06-03 | 1990-05-08 | Kaufman Herbert E | Artificial tear suspension |
| US5064655A (en) | 1989-02-24 | 1991-11-12 | Liposome Technology, Inc. | Liposome gel composition and method |
| US5075104A (en) | 1989-03-31 | 1991-12-24 | Alcon Laboratories, Inc. | Ophthalmic carboxy vinyl polymer gel for dry eye syndrome |
| US5174988A (en) | 1989-07-27 | 1992-12-29 | Scientific Development & Research, Inc. | Phospholipid delivery system |
| WO1991012808A1 (en) | 1990-02-22 | 1991-09-05 | Macnaught Pty Limited | Artificial tears |
| US5041434A (en) | 1991-08-17 | 1991-08-20 | Virginia Lubkin | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
| ES2084722T3 (es) | 1990-05-29 | 1996-05-16 | Boston Ocular Res | Composicion para tratamiento del ojo seco. |
| ZA912797B (en) | 1990-05-29 | 1992-12-30 | Boston Ocular Res | Dry eye treatment process and solution |
| US5102670A (en) | 1990-09-14 | 1992-04-07 | Abraham Nader G | Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels |
| JP2594486B2 (ja) | 1991-01-15 | 1997-03-26 | アルコン ラボラトリーズ インコーポレイテッド | 局所的眼薬組成物 |
| ZA927277B (en) | 1991-10-02 | 1993-05-19 | Boston Ocular Res | Dry eye treatment process and solution. |
| EP0546728A3 (en) | 1991-12-13 | 1993-09-08 | Alcon Laboratories Inc | Physiological tear compositions and methods for their preparation |
| CA2133966C (en) | 1992-04-21 | 1997-09-09 | David A. Sullivan | Ocular androgen therapy in sjogren's syndrome |
| US5290572A (en) | 1992-08-06 | 1994-03-01 | Deo Corporation | Opthalmic composition for treating dry eye |
| US5358706A (en) | 1992-09-30 | 1994-10-25 | Union Carbide Chemicals & Plastics Technology Corporation | Muco-adhesive polymers |
| US5455265A (en) | 1993-02-11 | 1995-10-03 | Allergan, Inc. | Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors |
| US5389383A (en) | 1993-06-18 | 1995-02-14 | Allergan, Inc. | Method for treating hypoxia-associated ocular complications |
| US5696166A (en) | 1995-10-31 | 1997-12-09 | Yanni; John M. | Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| IL130823A (en) | 1996-10-15 | 2005-12-18 | Elan Pharm Inc | Peptide-lipid conjugates, liposomes drug delivery |
| US5800807A (en) | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
| WO2000051619A1 (en) | 1999-03-01 | 2000-09-08 | Vista Scientific Llc | Mucin containing ophthalmic preparations |
-
2000
- 2000-10-23 WO PCT/US2000/029255 patent/WO2001034546A2/en active IP Right Grant
- 2000-10-23 JP JP2001536497A patent/JP2003513946A/ja not_active Withdrawn
- 2000-10-23 KR KR1020027004597A patent/KR20020050237A/ko not_active Application Discontinuation
- 2000-10-23 EP EP00982055A patent/EP1228031B1/en not_active Expired - Lifetime
- 2000-10-23 PL PL00356127A patent/PL356127A1/xx not_active Application Discontinuation
- 2000-10-23 AT AT00982055T patent/ATE257144T1/de not_active IP Right Cessation
- 2000-10-23 AU AU19131/01A patent/AU775290B2/en not_active Ceased
- 2000-10-23 MX MXPA02004699A patent/MXPA02004699A/es active IP Right Grant
- 2000-10-23 DE DE60007548T patent/DE60007548T2/de not_active Expired - Fee Related
- 2000-10-23 DK DK00982055T patent/DK1228031T3/da active
- 2000-10-23 US US09/694,144 patent/US6326499B1/en not_active Expired - Fee Related
- 2000-10-23 PT PT00982055T patent/PT1228031E/pt unknown
- 2000-10-23 BR BR0015402-4A patent/BR0015402A/pt not_active IP Right Cessation
- 2000-10-23 ES ES00982055T patent/ES2208440T3/es not_active Expired - Lifetime
- 2000-10-23 CN CN00815333A patent/CN1387504A/zh active Pending
- 2000-10-23 TR TR2002/01251T patent/TR200201251T2/xx unknown
- 2000-10-23 CA CA002386632A patent/CA2386632A1/en not_active Abandoned
- 2000-11-08 TW TW089123627A patent/TWI241290B/zh not_active IP Right Cessation
- 2000-11-08 AR ARP000105875A patent/AR030262A1/es not_active Application Discontinuation
-
2001
- 2001-09-20 US US09/957,102 patent/US6462061B1/en not_active Expired - Fee Related
-
2002
- 2002-10-05 HK HK02107321.3A patent/HK1045984B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1228031B1 (en) | 2004-01-02 |
| EP1228031A2 (en) | 2002-08-07 |
| ATE257144T1 (de) | 2004-01-15 |
| KR20020050237A (ko) | 2002-06-26 |
| HK1045984A1 (en) | 2002-12-20 |
| AU1913101A (en) | 2001-06-06 |
| US20020037881A1 (en) | 2002-03-28 |
| US6462061B1 (en) | 2002-10-08 |
| AU775290B2 (en) | 2004-07-29 |
| CA2386632A1 (en) | 2001-05-17 |
| ES2208440T3 (es) | 2004-06-16 |
| JP2003513946A (ja) | 2003-04-15 |
| PT1228031E (pt) | 2004-04-30 |
| US6326499B1 (en) | 2001-12-04 |
| PL356127A1 (en) | 2004-06-14 |
| MXPA02004699A (es) | 2004-09-10 |
| BR0015402A (pt) | 2002-06-25 |
| DE60007548D1 (de) | 2004-02-05 |
| HK1045984B (zh) | 2004-04-23 |
| DE60007548T2 (de) | 2004-06-17 |
| WO2001034546A3 (en) | 2001-10-25 |
| CN1387504A (zh) | 2002-12-25 |
| TWI241290B (en) | 2005-10-11 |
| DK1228031T3 (da) | 2004-04-13 |
| WO2001034546A2 (en) | 2001-05-17 |
| TR200201251T2 (tr) | 2002-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR003453A1 (es) | Inhibidores de agregado de plaquetas, su uso en la fabricacion de medicamentos, composicion farmaceutica que los contiene y procedimiento para la preparacion de dichos inhibidores | |
| AR037517A1 (es) | Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria | |
| ECSP941104A (es) | Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| PA8518701A1 (es) | Derivados de tiofeno utiles como agentes anticancerosos | |
| AR029634A1 (es) | Compuestos derivados heterociclicos utiles como agentes anticancerosos, composicion farmaceutica y procedimiento de tratamiento | |
| GT199800180A (es) | Derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos. | |
| ES2136037B1 (es) | Inhibidores de sulfamida-metaloproteasa | |
| MX9305769A (es) | Nuevos derivados de analogos del taxol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| UY27516A1 (es) | Bencimidazoles | |
| ES2104708T3 (es) | Compuestos heterociclicos terapeuticos. | |
| ES2196377T3 (es) | Derivados de naftiridina. | |
| IS6852A (is) | Efnasambönd | |
| ECSP045483A (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso | |
| AR012671A1 (es) | Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos | |
| CL2004000590A1 (es) | Compuestos derivados de 1,3,4-oxadiazol-3-ona, 1,3,4-tiadiazol-2-ona y de 1,2,4-triazol-3-ona; composicion farmaceutica que los contiene; procedimiento de preparacion y su uso en la preparacion de un medicamento en los que esta relacionado el virus v | |
| AR024060A1 (es) | Nuevos compuestos farmaceuticamente activos | |
| SV2003000633A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7 | |
| UY27700A1 (es) | Compuestos oxo - azabiclícos. | |
| ES2183332T3 (es) | Aminoacidos biciclicos aromaticos. | |
| UY27685A1 (es) | Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso | |
| AR030262A1 (es) | Derivados de acido 15-hidroxieicosatetraenoico modificados de cadena omega , composiciones que lo comprenden y el uso de los mismos para la manufactura de un medicamento para su utilizacion en el tratamiento del ojo seco | |
| PT919541E (pt) | Novos compostos naftalenicos processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
| UY25356A1 (es) | Polisacaridos de sintesis,procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| PT1057826E (pt) | Derivados carboxamidicos dimericos substituidos processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
| PT1233953E (pt) | Novos derivados de benzotiadiazinas processo para a sua preparacao e as composicoes farmaceuticas que os contem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |